Source recordFED

Cullis, Pieter R

Federal grants & contributions· Canadian Institutes of Health Research· FY2017· $2,121,669· BC

Description

Lipid nanomedicines for health and disease

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$2,121,669$0Original · 2016-07-01 (start date) · total $2,121,669
  • #02016-07-01$2,121,669
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2016-07-01(start date)$2,121,669—Lipid nanomedicines for health and disease

Related records · 5

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2023-2024-Q3-00813Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$1,082,476FY2024
236-2023-2024-Q2-00338Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$856,800FY2024
236-2023-2024-Q1-01452Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research$1,057,421FY2024
236-2020-2021-Q1-00046Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas$237,445FY2021
236-2018-2019-Q4-00341Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$9,472,000FY2019

Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q2-00066 · retrieved 2026-11-13.